Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'patients placebo'
patients placebo published presentations and documents on DocSlides.
Bruix J et al. Lancet 2017;389(10064):56-66.
by kittie-lecroy
Regorafenib. 160 mg/d. (n = 379). Placebo. (n = ...
Peter Fisher FRCP, FFHom
by olivia-moreira
Director of Research. Royal London Hospital for I...
Michael S. Saag , MD Eric S.
by pamella-moone
Daar. , MD. Antiretroviral Therapy:. A Case-Based...
Aperçu des essais cliniques
by jane-oiler
2. Syndrome du côlon irritable avec constipation...
The EINSTEIN EXT Study 'Xarelto' for
by tatiana-dople
the . Long-Term Prevention of Recurrent Venous Th...
Novel Biologic Therapies for
by olivia-moreira
Second-Line Gastric Cancer. Charles S. Fuchs, MD....
Why Do We Treat Obesity?
by myesha-ticknor
Metabolic Complications. 2. Diabetes Risk. Metabo...
Randomized Controlled Trials of Methotrexate & Mycophen
by liane-varnes
Richard J. Barohn, MD. Chair, Department of Neuro...
Prevention of Postoperative Crohn’s disease
by jane-oiler
Miguel Regueiro, M.D.. Professor of Medicine. Ass...
Heart Failure Management
by faustina-dinatale
(2013 Updated Guidelines). Blake Wachter, MD, PhD...
ACCP Cardiology PRN Journal Club
by tatiana-dople
Announcements . Thank you attending the ACCP Card...
LUTS –
by danika-pritchard
Nocturia. & Incontinence. Recurrent UTI. ’...
Cardiovascular outcomes
by lois-ondreau
Silvio E Inzucchi. Professor of . Medicine. , . Y...
LUTS –
by pamella-moone
Nocturia. & Incontinence. Recurrent UTI. ’...
Vascular effects of
by sherrill-nordquist
PPAR . . . activation:. Endothelial function....
Improving the Management of Postoperative Pain
by tatyana-admore
:. . Multimodal . Approaches . in . Clinical Pra...
CHARLENE D. FELL, MD, MSc
by pamella-moone
PULMONARY FIBROSIS MANAGEMENT STRATEGIES I. NOVEM...
MultipleSclerosis:Current&Emerging
by yoshiko-marsland
Treatments Personalized Strategies. Dr. Suhail A...
New drugs and regimens for TB: 2015 update
by test
Scott K. . Heysell. MD, MPH. (no disclosures). W...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
Vascular effects of
by yoshiko-marsland
PPAR . . . activation:. Endothelial function....
Protecting the heart and the kidney:
by marina-yarberry
Implications from the SHARP trial. Dr. Christina ...
Farnesoid
by olivia-moreira
X . nuclear. . receptor. . ligand. . obeticho...
Similarly, a statistically significant MADRS reduction over
by celsa-spraggs
At discharge, 77.8% of patients with mixed states...
Description:-
by giovanna-bartolotta
The spice ginger is the underground rhizome of th...
TZD’s in the management of diabetes & CV disease: All
by conchita-marotz
Prof. John Betteridge, MD. University College Lon...
Efficacy
by yoshiko-marsland
. of. . Obeticholic. . Acid. in . Patients. ...
Targeting KRAS and down streaming
by alexa-scheidler
pathways. Federico Cappuzzo. Istituto Toscano Tum...
OMICS
by phoebe-click
International . welcomes submissions that are ori...
The Case for Vitamin D
by stefany-barnette
John J Cannell, MD. Executive Director, Vitamin D...
Illuminating
by trish-goza
the Fine Print: . Visualizing . Medication . Side...
New drugs and regimens for TB: 2015 update
by pasty-toler
Scott K. . Heysell. MD, MPH. (no disclosures). W...
Thrice-Weekly Glatiramer Acetate for Relapsing Forms of Mul
by yoshiko-marsland
Fred D. Lublin, MD . Saunders Family Professor . ...
ACCP Cardiology PRN Journal Club
by karlyn-bohler
Announcements . Thank you attending the ACCP Card...
The Soluble Guanylate Cyclase Stimulator Vericiguat in Wors
by alexa-scheidler
SOCRATES-REDUCED . D. ose Finding . P. hase II ....
Efficacy and Safety of Crisaborole Ointment, a
by calandra-battersby
Efficacy and Safety of Crisaborole Ointment, a Nov...
Load More...
